nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergocalciferol—CYP3A4—bone cancer	0.67	1	CbGaD
Ergocalciferol—CYP27A1—vertebral column—bone cancer	0.0131	0.103	CbGeAlD
Ergocalciferol—CYP2R1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0131	0.0718	CbGpPWpGaD
Ergocalciferol—CYP27A1—leg—bone cancer	0.0126	0.0991	CbGeAlD
Ergocalciferol—CYP27A1—forelimb—bone cancer	0.0125	0.0983	CbGeAlD
Ergocalciferol—VDR—periosteum—bone cancer	0.0114	0.0897	CbGeAlD
Ergocalciferol—CYP27A1—hindlimb—bone cancer	0.0112	0.0885	CbGeAlD
Ergocalciferol—CYP27A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0101	0.0555	CbGpPWpGaD
Ergocalciferol—CYP27A1—appendage—bone cancer	0.00964	0.0759	CbGeAlD
Ergocalciferol—CYP27B1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00958	0.0526	CbGpPWpGaD
Ergocalciferol—VDR—vertebral column—bone cancer	0.00944	0.0743	CbGeAlD
Ergocalciferol—VDR—leg—bone cancer	0.00909	0.0715	CbGeAlD
Ergocalciferol—VDR—forelimb—bone cancer	0.00902	0.071	CbGeAlD
Ergocalciferol—CYP24A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00814	0.0447	CbGpPWpGaD
Ergocalciferol—VDR—hindlimb—bone cancer	0.00811	0.0639	CbGeAlD
Ergocalciferol—VDR—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00715	0.0392	CbGpPWpGaD
Ergocalciferol—VDR—appendage—bone cancer	0.00696	0.0548	CbGeAlD
Ergocalciferol—Irreversible renal failure—Cisplatin—bone cancer	0.00654	0.385	CcSEcCtD
Ergocalciferol—VDR—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00642	0.0352	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metapathway biotransformation—CYP4V2—bone cancer	0.00563	0.0309	CbGpPWpGaD
Ergocalciferol—CYP27B1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00517	0.0284	CbGpPWpGaD
Ergocalciferol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0044	0.0242	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00435	0.0239	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metapathway biotransformation—CYP4V2—bone cancer	0.00412	0.0226	CbGpPWpGaD
Ergocalciferol—VDR—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00375	0.0206	CbGpPWpGaD
Ergocalciferol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00369	0.0202	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metapathway biotransformation—CYP4V2—bone cancer	0.0035	0.0192	CbGpPWpGaD
Ergocalciferol—VDR—Nuclear Receptors—NR1I2—bone cancer	0.00337	0.0185	CbGpPWpGaD
Ergocalciferol—CYP27B1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00302	0.0166	CbGpPWpGaD
Ergocalciferol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.00288	0.0158	CbGpPWpGaD
Ergocalciferol—CYP27A1—connective tissue—bone cancer	0.00275	0.0217	CbGeAlD
Ergocalciferol—VDR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00267	0.0146	CbGpPWpGaD
Ergocalciferol—CYP2R1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00262	0.0144	CbGpPWpGaD
Ergocalciferol—CYP2R1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00259	0.0142	CbGpPWpGaD
Ergocalciferol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00257	0.0141	CbGpPWpGaD
Ergocalciferol—Renal failure chronic—Cisplatin—bone cancer	0.00229	0.135	CcSEcCtD
Ergocalciferol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00215	0.0118	CbGpPWpGaD
Ergocalciferol—CYP2R1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00213	0.0117	CbGpPWpGaD
Ergocalciferol—AR—Nuclear Receptors—NR1I2—bone cancer	0.00208	0.0114	CbGpPWpGaD
Ergocalciferol—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00202	0.0111	CbGpPWpGaD
Ergocalciferol—CYP27A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.002	0.011	CbGpPWpGaD
Ergocalciferol—VDR—connective tissue—bone cancer	0.00199	0.0156	CbGeAlD
Ergocalciferol—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.00199	0.0109	CbGpPWpGaD
Ergocalciferol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00192	0.0105	CbGpPWpGaD
Ergocalciferol—CYP27B1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00189	0.0104	CbGpPWpGaD
Ergocalciferol—CYP27A1—tendon—bone cancer	0.00189	0.0149	CbGeAlD
Ergocalciferol—CYP27A1—spinal cord—bone cancer	0.00182	0.0144	CbGeAlD
Ergocalciferol—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00164	0.00903	CbGpPWpGaD
Ergocalciferol—CYP27A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00164	0.00901	CbGpPWpGaD
Ergocalciferol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00163	0.00896	CbGpPWpGaD
Ergocalciferol—CYP24A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00161	0.00884	CbGpPWpGaD
Ergocalciferol—CYP27B1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00156	0.00854	CbGpPWpGaD
Ergocalciferol—Paricalcitol—CYP3A4—bone cancer	0.00141	0.384	CrCbGaD
Ergocalciferol—Calcitriol—CYP3A4—bone cancer	0.00141	0.384	CrCbGaD
Ergocalciferol—VDR—Ovarian Infertility Genes—CDK4—bone cancer	0.0014	0.0077	CbGpPWpGaD
Ergocalciferol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00139	0.00763	CbGpPWpGaD
Ergocalciferol—VDR—tendon—bone cancer	0.00137	0.0107	CbGeAlD
Ergocalciferol—VDR—Generic Transcription Pathway—ZNF77—bone cancer	0.00136	0.00747	CbGpPWpGaD
Ergocalciferol—VDR—bone marrow—bone cancer	0.00132	0.0104	CbGeAlD
Ergocalciferol—CYP24A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00132	0.00726	CbGpPWpGaD
Ergocalciferol—AR—connective tissue—bone cancer	0.00121	0.00954	CbGeAlD
Ergocalciferol—CYP2R1—Biological oxidations—CYP3A4—bone cancer	0.00113	0.0062	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metapathway biotransformation—CYP3A4—bone cancer	0.00111	0.00611	CbGpPWpGaD
Ergocalciferol—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00106	0.0058	CbGpPWpGaD
Ergocalciferol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000994	0.00546	CbGpPWpGaD
Ergocalciferol—CYP2R1—Biological oxidations—GSTP1—bone cancer	0.000965	0.0053	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metapathway biotransformation—GSTP1—bone cancer	0.000952	0.00523	CbGpPWpGaD
Ergocalciferol—CYP27A1—Biological oxidations—CYP3A4—bone cancer	0.000872	0.00479	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metapathway biotransformation—CYP3A4—bone cancer	0.00086	0.00472	CbGpPWpGaD
Ergocalciferol—Cholecalciferol—CYP3A4—bone cancer	0.000856	0.233	CrCbGaD
Ergocalciferol—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.000839	0.00461	CbGpPWpGaD
Ergocalciferol—AR—tendon—bone cancer	0.000833	0.00656	CbGeAlD
Ergocalciferol—CYP27B1—Biological oxidations—CYP3A4—bone cancer	0.000826	0.00454	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metapathway biotransformation—CYP3A4—bone cancer	0.000815	0.00448	CbGpPWpGaD
Ergocalciferol—AR—spinal cord—bone cancer	0.000804	0.00632	CbGeAlD
Ergocalciferol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000764	0.0042	CbGpPWpGaD
Ergocalciferol—CYP27A1—Biological oxidations—GSTP1—bone cancer	0.000745	0.00409	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metapathway biotransformation—GSTP1—bone cancer	0.000735	0.00404	CbGpPWpGaD
Ergocalciferol—CYP27B1—Biological oxidations—GSTP1—bone cancer	0.000707	0.00388	CbGpPWpGaD
Ergocalciferol—CYP24A1—Biological oxidations—CYP3A4—bone cancer	0.000703	0.00386	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metapathway biotransformation—GSTP1—bone cancer	0.000697	0.00383	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000693	0.00381	CbGpPWpGaD
Ergocalciferol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—bone cancer	0.000684	0.00375	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—NDUFA12—bone cancer	0.000677	0.00372	CbGpPWpGaD
Ergocalciferol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000667	0.00366	CbGpPWpGaD
Ergocalciferol—VDR—Gene Expression—ZNF77—bone cancer	0.000655	0.0036	CbGpPWpGaD
Ergocalciferol—Pain—Carboplatin—bone cancer	0.000641	0.0378	CcSEcCtD
Ergocalciferol—Azotaemia—Methotrexate—bone cancer	0.000635	0.0374	CcSEcCtD
Ergocalciferol—Osteoporosis—Methotrexate—bone cancer	0.000603	0.0355	CcSEcCtD
Ergocalciferol—CYP24A1—Biological oxidations—GSTP1—bone cancer	0.000601	0.0033	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metapathway biotransformation—GSTP1—bone cancer	0.000593	0.00325	CbGpPWpGaD
Ergocalciferol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000571	0.00313	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—NT5C3A—bone cancer	0.000561	0.00308	CbGpPWpGaD
Ergocalciferol—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.000553	0.00303	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metabolism—NDUFA12—bone cancer	0.000522	0.00287	CbGpPWpGaD
Ergocalciferol—Polyuria—Cisplatin—bone cancer	0.000509	0.03	CcSEcCtD
Ergocalciferol—CYP27B1—Metabolism—NDUFA12—bone cancer	0.000495	0.00272	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000474	0.0026	CbGpPWpGaD
Ergocalciferol—VDR—Generic Transcription Pathway—NR1I2—bone cancer	0.00046	0.00253	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000455	0.0025	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metabolism—NT5C3A—bone cancer	0.000433	0.00238	CbGpPWpGaD
Ergocalciferol—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000432	0.00237	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—MET—bone cancer	0.00043	0.00236	CbGpPWpGaD
Ergocalciferol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.00043	0.00236	CbGpPWpGaD
Ergocalciferol—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000428	0.00235	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—NDUFA12—bone cancer	0.000421	0.00231	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000413	0.00227	CbGpPWpGaD
Ergocalciferol—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000411	0.00226	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—NT5C3A—bone cancer	0.00041	0.00225	CbGpPWpGaD
Ergocalciferol—AR—Gene Expression—ZNF77—bone cancer	0.000404	0.00222	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000403	0.00221	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000397	0.00218	CbGpPWpGaD
Ergocalciferol—Musculoskeletal stiffness—Methotrexate—bone cancer	0.000377	0.0222	CcSEcCtD
Ergocalciferol—VDR—Direct p53 effectors—RB1—bone cancer	0.000374	0.00205	CbGpPWpGaD
Ergocalciferol—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000372	0.00204	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000367	0.00201	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—MMP2—bone cancer	0.000359	0.00197	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—NT5C3A—bone cancer	0.000349	0.00192	CbGpPWpGaD
Ergocalciferol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000346	0.0019	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000345	0.00189	CbGpPWpGaD
Ergocalciferol—Nocturia—Epirubicin—bone cancer	0.000341	0.0201	CcSEcCtD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000337	0.00185	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000334	0.00183	CbGpPWpGaD
Ergocalciferol—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000332	0.00182	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000329	0.00181	CbGpPWpGaD
Ergocalciferol—VDR—Gene Expression—FUS—bone cancer	0.00032	0.00176	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—MDM2—bone cancer	0.000319	0.00175	CbGpPWpGaD
Ergocalciferol—Nocturia—Doxorubicin—bone cancer	0.000316	0.0186	CcSEcCtD
Ergocalciferol—Urine output increased—Methotrexate—bone cancer	0.000306	0.018	CcSEcCtD
Ergocalciferol—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.000284	0.00156	CbGpPWpGaD
Ergocalciferol—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.000283	0.00155	CbGpPWpGaD
Ergocalciferol—Polyuria—Methotrexate—bone cancer	0.000279	0.0165	CcSEcCtD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000279	0.00153	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—JUN—bone cancer	0.000277	0.00152	CbGpPWpGaD
Ergocalciferol—Mental disability—Epirubicin—bone cancer	0.000275	0.0162	CcSEcCtD
Ergocalciferol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000268	0.00147	CbGpPWpGaD
Ergocalciferol—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000265	0.00145	CbGpPWpGaD
Ergocalciferol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.00026	0.00143	CbGpPWpGaD
Ergocalciferol—Mental disability—Doxorubicin—bone cancer	0.000254	0.015	CcSEcCtD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.00025	0.00137	CbGpPWpGaD
Ergocalciferol—Anaemia—Cisplatin—bone cancer	0.000249	0.0147	CcSEcCtD
Ergocalciferol—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.000246	0.00135	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—ENO2—bone cancer	0.000246	0.00135	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—DHFR—bone cancer	0.000228	0.00125	CbGpPWpGaD
Ergocalciferol—VDR—Gene Expression—NR1I2—bone cancer	0.000222	0.00122	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000221	0.00121	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—EGFR—bone cancer	0.000218	0.0012	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000217	0.00119	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—GNA11—bone cancer	0.000213	0.00117	CbGpPWpGaD
Ergocalciferol—Anorexia—Cisplatin—bone cancer	0.00021	0.0123	CcSEcCtD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000207	0.00114	CbGpPWpGaD
Ergocalciferol—AR—Gene Expression—FUS—bone cancer	0.000197	0.00108	CbGpPWpGaD
Ergocalciferol—AR—Androgen receptor signaling pathway—EGFR—bone cancer	0.000193	0.00106	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism—CYP3A4—bone cancer	0.000193	0.00106	CbGpPWpGaD
Ergocalciferol—CYP2R1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000192	0.00105	CbGpPWpGaD
Ergocalciferol—Decreased appetite—Cisplatin—bone cancer	0.000191	0.0113	CcSEcCtD
Ergocalciferol—CYP27A1—Metabolism—ENO2—bone cancer	0.00019	0.00104	CbGpPWpGaD
Ergocalciferol—Pain—Cisplatin—bone cancer	0.000188	0.0111	CcSEcCtD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000185	0.00102	CbGpPWpGaD
Ergocalciferol—VDR—Direct p53 effectors—TP53—bone cancer	0.000183	0.00101	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—ENO2—bone cancer	0.00018	0.000987	CbGpPWpGaD
Ergocalciferol—Weight decreased—Epirubicin—bone cancer	0.00018	0.0106	CcSEcCtD
Ergocalciferol—CYP27A1—Metabolism—DHFR—bone cancer	0.000176	0.000966	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—DHFR—bone cancer	0.000167	0.000916	CbGpPWpGaD
Ergocalciferol—Weight decreased—Doxorubicin—bone cancer	0.000166	0.00979	CcSEcCtD
Ergocalciferol—CYP2R1—Metabolism—GSTP1—bone cancer	0.000165	0.000907	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metabolism—GNA11—bone cancer	0.000164	0.000903	CbGpPWpGaD
Ergocalciferol—VDR—Gene Expression—EIF2S1—bone cancer	0.000164	0.000899	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000161	0.000884	CbGpPWpGaD
Ergocalciferol—Asthenia—Cisplatin—bone cancer	0.000158	0.00929	CcSEcCtD
Ergocalciferol—AR—SIDS Susceptibility Pathways—JUN—bone cancer	0.000157	0.000861	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—GNA11—bone cancer	0.000156	0.000856	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000153	0.000843	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—ENO2—bone cancer	0.000153	0.000839	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metabolism—CYP3A4—bone cancer	0.000149	0.000819	CbGpPWpGaD
Ergocalciferol—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000148	0.000814	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000148	0.000812	CbGpPWpGaD
Ergocalciferol—VDR—Gene Expression—EZH2—bone cancer	0.000142	0.000781	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—DHFR—bone cancer	0.000142	0.000779	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—CYP3A4—bone cancer	0.000141	0.000776	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000141	0.000772	CbGpPWpGaD
Ergocalciferol—AR—Gene Expression—NR1I2—bone cancer	0.000137	0.000751	CbGpPWpGaD
Ergocalciferol—Anaemia—Methotrexate—bone cancer	0.000137	0.00805	CcSEcCtD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000133	0.000733	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—GNA11—bone cancer	0.000133	0.000728	CbGpPWpGaD
Ergocalciferol—Nausea—Cisplatin—bone cancer	0.000131	0.00769	CcSEcCtD
Ergocalciferol—Anaemia—Epirubicin—bone cancer	0.000128	0.00753	CcSEcCtD
Ergocalciferol—CYP27A1—Metabolism—GSTP1—bone cancer	0.000127	0.0007	CbGpPWpGaD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000127	0.000695	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—GSTP1—bone cancer	0.000121	0.000664	CbGpPWpGaD
Ergocalciferol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.00012	0.000661	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—CYP3A4—bone cancer	0.00012	0.00066	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.00012	0.000656	CbGpPWpGaD
Ergocalciferol—Hypertension—Epirubicin—bone cancer	0.000119	0.00703	CcSEcCtD
Ergocalciferol—Anaemia—Doxorubicin—bone cancer	0.000118	0.00697	CcSEcCtD
Ergocalciferol—Anorexia—Methotrexate—bone cancer	0.000115	0.00677	CcSEcCtD
Ergocalciferol—Hypertension—Doxorubicin—bone cancer	0.00011	0.00651	CcSEcCtD
Ergocalciferol—Anorexia—Epirubicin—bone cancer	0.000108	0.00634	CcSEcCtD
Ergocalciferol—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000106	0.000584	CbGpPWpGaD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000105	0.000576	CbGpPWpGaD
Ergocalciferol—Decreased appetite—Methotrexate—bone cancer	0.000105	0.00618	CcSEcCtD
Ergocalciferol—Pain—Methotrexate—bone cancer	0.000103	0.00608	CcSEcCtD
Ergocalciferol—CYP24A1—Metabolism—GSTP1—bone cancer	0.000103	0.000564	CbGpPWpGaD
Ergocalciferol—AR—Gene Expression—EIF2S1—bone cancer	0.000101	0.000554	CbGpPWpGaD
Ergocalciferol—Anorexia—Doxorubicin—bone cancer	9.96e-05	0.00586	CcSEcCtD
Ergocalciferol—Decreased appetite—Epirubicin—bone cancer	9.81e-05	0.00578	CcSEcCtD
Ergocalciferol—Pain—Epirubicin—bone cancer	9.65e-05	0.00569	CcSEcCtD
Ergocalciferol—Constipation—Epirubicin—bone cancer	9.65e-05	0.00569	CcSEcCtD
Ergocalciferol—Decreased appetite—Doxorubicin—bone cancer	9.08e-05	0.00535	CcSEcCtD
Ergocalciferol—Constipation—Doxorubicin—bone cancer	8.93e-05	0.00526	CcSEcCtD
Ergocalciferol—Pain—Doxorubicin—bone cancer	8.93e-05	0.00526	CcSEcCtD
Ergocalciferol—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.81e-05	0.000484	CbGpPWpGaD
Ergocalciferol—AR—Gene Expression—EZH2—bone cancer	8.77e-05	0.000482	CbGpPWpGaD
Ergocalciferol—Asthenia—Methotrexate—bone cancer	8.65e-05	0.0051	CcSEcCtD
Ergocalciferol—CYP2R1—Metabolism—PTGS2—bone cancer	8.55e-05	0.00047	CbGpPWpGaD
Ergocalciferol—Asthenia—Epirubicin—bone cancer	8.1e-05	0.00477	CcSEcCtD
Ergocalciferol—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.8e-05	0.000428	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.69e-05	0.000422	CbGpPWpGaD
Ergocalciferol—Asthenia—Doxorubicin—bone cancer	7.49e-05	0.00441	CcSEcCtD
Ergocalciferol—Nausea—Methotrexate—bone cancer	7.16e-05	0.00422	CcSEcCtD
Ergocalciferol—Nausea—Epirubicin—bone cancer	6.7e-05	0.00395	CcSEcCtD
Ergocalciferol—CYP27A1—Metabolism—PTGS2—bone cancer	6.6e-05	0.000363	CbGpPWpGaD
Ergocalciferol—CYP27B1—Metabolism—PTGS2—bone cancer	6.26e-05	0.000344	CbGpPWpGaD
Ergocalciferol—Nausea—Doxorubicin—bone cancer	6.2e-05	0.00365	CcSEcCtD
Ergocalciferol—CYP3A4—Metabolism—NDUFA12—bone cancer	5.46e-05	0.0003	CbGpPWpGaD
Ergocalciferol—CYP24A1—Metabolism—PTGS2—bone cancer	5.32e-05	0.000292	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—NT5C3A—bone cancer	4.53e-05	0.000249	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—ENO2—bone cancer	1.98e-05	0.000109	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—DHFR—bone cancer	1.84e-05	0.000101	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—GNA11—bone cancer	1.72e-05	9.44e-05	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—GSTP1—bone cancer	1.33e-05	7.32e-05	CbGpPWpGaD
Ergocalciferol—CYP3A4—Metabolism—PTGS2—bone cancer	6.91e-06	3.79e-05	CbGpPWpGaD
